Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pellat

Showing results (101-110 of 320) with videos related to

Pageof 32
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2009
TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} productionDavid Chiron, Catherine Pellat-Deceunynck, Martine Amiot, et al.
Bulletin Du Cancer|March 19, 2023
[Well-differentiated neuroendocrine tumors of the digestive tract: Focus on pancreatic neuroendocrine tumors]Anna Pellat, Maxime Barat, Anne-Ségolène Cottereau, et al.
Neuropsychology|May 3, 2000
Working memory functioning in medicated Parkinson's disease patients and the effect of withdrawal of dopaminergic medicationN Fournet, O Moreaud, J L Roulin, et al.
Journal De Chirurgie|August 1, 1978
[Report of 39 traumatic and iatrogenic lesions of the extra-cranial carotid artery (author's transl)]J L Vinard, H Guidicelli, M Pellat, et al.
Therapie|November 1, 1981
[Acute study of the association of bromocriptine and domperidone in parkinsonism (author's transl)]P Pollak, J M Gaio, M Hommel, et al.
Cancer Research|April 15, 1996
CD11a-CD18 and CD102 interactions mediate human myeloma cell growth arrest induced by CD40 stimulationC Pellat-Deceunynck, M Amiot, N Robillard, et al.
La Nouvelle Presse Medicale|December 11, 1976
[Hepatitis following methyldopa]J P Thery, J Fournet, J H Bonnet-Eymard, et al.
Psychopharmacology|January 1, 1985
Effects of tiapride in tardive dyskinesiaP Pollak, J M Gaio, M Hommel, et al.
Epilepsy & Behavior : E&B|August 6, 2003
Dramatic changes in artistic preference after left temporal lobectomyFrançois Sellal, Marcellin Andriantseheno, Laurent Vercueil, et al.
Blood|July 2, 2008
Toll-like receptors: lessons to learn from normal and malignant human B cellsDavid Chiron, Isabelle Bekeredjian-Ding, Catherine Pellat-Deceunynck, et al.
Pageof 32

Showing results (101-110 of 320) with videos related to

Sort By:
Pageof 32
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2009
TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} productionDavid Chiron, Catherine Pellat-Deceunynck, Martine Amiot, et al.
Bulletin Du Cancer|March 19, 2023
[Well-differentiated neuroendocrine tumors of the digestive tract: Focus on pancreatic neuroendocrine tumors]Anna Pellat, Maxime Barat, Anne-Ségolène Cottereau, et al.
Neuropsychology|May 3, 2000
Working memory functioning in medicated Parkinson's disease patients and the effect of withdrawal of dopaminergic medicationN Fournet, O Moreaud, J L Roulin, et al.
Journal De Chirurgie|August 1, 1978
[Report of 39 traumatic and iatrogenic lesions of the extra-cranial carotid artery (author's transl)]J L Vinard, H Guidicelli, M Pellat, et al.
Therapie|November 1, 1981
[Acute study of the association of bromocriptine and domperidone in parkinsonism (author's transl)]P Pollak, J M Gaio, M Hommel, et al.
Cancer Research|April 15, 1996
CD11a-CD18 and CD102 interactions mediate human myeloma cell growth arrest induced by CD40 stimulationC Pellat-Deceunynck, M Amiot, N Robillard, et al.
La Nouvelle Presse Medicale|December 11, 1976
[Hepatitis following methyldopa]J P Thery, J Fournet, J H Bonnet-Eymard, et al.
Psychopharmacology|January 1, 1985
Effects of tiapride in tardive dyskinesiaP Pollak, J M Gaio, M Hommel, et al.
Epilepsy & Behavior : E&B|August 6, 2003
Dramatic changes in artistic preference after left temporal lobectomyFrançois Sellal, Marcellin Andriantseheno, Laurent Vercueil, et al.
Blood|July 2, 2008
Toll-like receptors: lessons to learn from normal and malignant human B cellsDavid Chiron, Isabelle Bekeredjian-Ding, Catherine Pellat-Deceunynck, et al.
Pageof 32